{"id":"https://openalex.org/W177698552","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_325-c","title":"Abstract 1439: Cytochrome P450 Genetic Variants Predict Cardiovascular Outcomes following Treatment with Clopidogrel but not with Prasugrel","display_name":"Abstract 1439: Cytochrome P450 Genetic Variants Predict Cardiovascular Outcomes following Treatment with Clopidogrel but not with Prasugrel","publication_year":2008,"publication_date":"2008-10-28","ids":{"openalex":"https://openalex.org/W177698552","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_325-c","mag":"177698552"},"language":"en","primary_location":{"id":"doi:10.1161/circ.118.suppl_18.s_325-c","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_325-c","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.118.suppl_18.s_325-c","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062053709","display_name":"Jessica L. Mega","orcid":"https://orcid.org/0000-0003-2640-9624","observed_orcids":["https://orcid.org/0000-0003-2640-9624"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica L Mega","raw_affiliation_strings":["Brigham and Women\u2019s Hosp, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hosp, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090522460","display_name":"Lei Shen","orcid":"https://orcid.org/0000-0003-4040-8716","observed_orcids":["https://orcid.org/0000-0003-4040-8716"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Shen","raw_affiliation_strings":["Eli Lilly Rsch, Laboratories, Indianapolis, IN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Rsch, Laboratories, Indianapolis, IN;","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107928205","display_name":"Stephen D. Wiviott","orcid":"https://orcid.org/0000-0002-4922-9880","observed_orcids":["https://orcid.org/0000-0002-4922-9880"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen D Wiviott","raw_affiliation_strings":["Brigham and Women\u2019s Hosp, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hosp, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112384581","display_name":"Joseph R. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph R Walker","raw_affiliation_strings":["Daiichi Sankyo Pharma Development, Edison, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Pharma Development, Edison, MA","institution_ids":["https://openalex.org/I4210162815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060350471","display_name":"Richard D. Hockett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard D Hockett","raw_affiliation_strings":["Eli Lilly Rsch Laboratories, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Rsch Laboratories, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109951394","display_name":"John T. Brandt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John T Brandt","raw_affiliation_strings":["Eli Lilly Rsch Laboratories, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Rsch Laboratories, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037041032","display_name":"Brian A. Moser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian A Moser","raw_affiliation_strings":["Eli Lilly Rsch Laboratories, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Rsch Laboratories, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032492386","display_name":"William L. Macias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Macias","raw_affiliation_strings":["Eli Lilly Rsch Laboratories, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Rsch Laboratories, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019612250","display_name":"Elliott Marshall Antman","orcid":"https://orcid.org/0000-0002-0808-9199","observed_orcids":["https://orcid.org/0000-0002-0808-9199"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elliott M Antman","raw_affiliation_strings":["Brigham and Women\u2019s Hosp, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hosp, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038207584","display_name":"Sandra L. Close","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra L Close","raw_affiliation_strings":["Rsch Laboratories, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rsch Laboratories, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109491831","display_name":"Eli Lilly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eli Lilly","raw_affiliation_strings":["Rsch Laboratories, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rsch Laboratories, Indianapolis, IN","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030057930","display_name":"Marc Steven Sabatine","orcid":"https://orcid.org/0000-0002-0691-3359","observed_orcids":["https://orcid.org/0000-0002-0691-3359"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc S Sabatine","raw_affiliation_strings":["Brigham and Women\u2019s Hosp, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hosp, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"118","issue":"suppl_18","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.027699999511241913,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.8799999952316284},{"id":"https://openalex.org/keywords/prasugrel","display_name":"prasugrel","score":1.0},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.7239999771118164},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.8679999709129333},{"id":"https://openalex.org/keywords/stent-thrombosis","display_name":"stent thrombosis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.5989999771118164},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9869999885559082},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.8299999833106995},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8199999928474426},{"id":"https://openalex.org/keywords/triton-timi-38","display_name":"TRITON-TIMI 38","score":0.8700000047683716},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.6539999842643738},{"id":"https://openalex.org/keywords/genotype-guided-therapy","display_name":"genotype-guided therapy","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C2777028646","wikidata":"https://www.wikidata.org/wiki/Q416232","display_name":"Prasugrel","level":4,"score":0.9345434904098511},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.9210653901100159},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.905932605266571},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8468098044395447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6247061491012573},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.4944021701812744},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4815097749233246},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4709416627883911},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.4404909014701843},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.42804449796676636},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39735135436058044},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3537270426750183},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.12320747971534729},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.118.suppl_18.s_325-c","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_325-c","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.118.suppl_18.s_325-c","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2128228188","https://openalex.org/W1709234658","https://openalex.org/W1993518253","https://openalex.org/W2039599826","https://openalex.org/W2398742900","https://openalex.org/W3045061473","https://openalex.org/W6887705159","https://openalex.org/W1985059672","https://openalex.org/W1518311777","https://openalex.org/W2904274506"],"abstract_inverted_index":{"Background":[0],":":[1,50,115,223],"Prasugrel":[2],"and":[3,29,98,100,150,201,220,239],"clopidogrel":[4,33,68,247],"require":[5],"transformation":[6],"into":[7],"active":[8],"metabolites":[9],"by":[10],"cytochrome":[11],"P450":[12],"(CYP)":[13],"enzymes.":[14],"Variants":[15],"in":[16,43,80,89],"CYP":[17,44,218],"genes,":[18],"particularly":[19],"CYP2C19":[20,90,121,172,224,255],",":[21,91,93,95,97],"are":[22],"associated":[23],"w/":[24,32,56,166,205],"reduced":[25,111,122,173],"levels":[26],"of":[27,41,109,127,134,139,155,182],"metabolite":[28],"platelet":[30],"inhibition":[31],"but":[34,248],"not":[35,178,249],"prasugrel.":[36,254],"We":[37],"investigated":[38],"the":[39,135,258],"impact":[40],"variants":[42,226],"genes":[45],"on":[46],"clinical":[47],"outcomes.":[48,221],"Methods":[49],"TRITON-TIMI":[51],"38":[52],"randomized":[53],"ACS":[54],"patients":[55,228],"planned":[57],"PCI":[58],"to":[59,260],"prasugrel":[60,171],"(60":[61],"mg":[62,65,72],"load,":[63],"10":[64],"qd)":[66,73],"or":[67,107,143,158,186,191,237],"(300":[69],"mg,":[70],"75":[71],"for":[74,86,102,233,240],"6\u201315":[75],"mos.":[76],"DNA":[77],"was":[78,203],"available":[79],"2943":[81],"subjects":[82,117],"who":[83],"were":[84,177,209],"genotyped":[85],"functional":[87],"polymorphisms":[88],"2C9":[92],"3A4/5":[94],"2B6":[96],"1A2":[99],"classified":[101],"each":[103],"gene":[104],"as":[105],"carriers":[106,125,176],"non-carriers":[108],"\u22651":[110],"function":[112,123,174],"allele.":[113],"Results":[114],"Among":[116],"treated":[118,245,252],"with":[119,170,246,253],"clopidogrel,":[120],"allele":[124,175],"(27%":[126],"population)":[128],"had":[129],"a":[130,151],"53%":[131],"increased":[132,153,180],"risk":[133,154,181,232],"primary":[136],"efficacy":[137],"endpoint":[138],"CV":[140,183,234],"death,":[141,184,235],"MI,":[142,185,236],"stroke":[144,187,238],"(HR":[145,162,188,194],"1.53,":[146],"P=0.007,":[147],"Fig":[148],")":[149],"3-fold":[152],"ARC-defined":[156],"definite":[157],"probable":[159],"stent":[160,192,241],"thrombosis":[161,193,242],"3.09,":[163],"P=0.038)":[164],"compared":[165],"non-carriers.":[167],"In":[168],"contrast,":[169],"at":[179,229],"0.89,":[189],"P=0.86)":[190],"0.60,":[195],"P=0.57).":[196],"No":[197],"association":[198],"between":[199,214],"genotype":[200],"bleeding":[202],"observed":[204],"either":[206],"treatment.":[207],"There":[208],"no":[210],"statistically":[211],"significant":[212],"associations":[213],"any":[215],"other":[216],"tested":[217],"genotypes":[219],"Conclusions":[222],"genetic":[225],"identify":[227],"significantly":[230],"higher":[231],"among":[243,250],"those":[244,251],"genotyping":[256],"offers":[257],"potential":[259],"help":[261],"tailor":[262],"antiplatelet":[263],"therapy.":[264]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2016-06-24T00:00:00"}